Immediate Impact
2 hit
Citing Papers
Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis
2021 Hit
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis
2021 Hit
Works of Josef Gutman being referenced
COVID-19 outcomes in MS
2020